{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:27:58Z","timestamp":1715128078139},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Irving Harris Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1245\/s10434-024-15155-6","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:02:33Z","timestamp":1710849753000},"page":"3785-3786","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma"],"prefix":"10.1245","volume":"31","author":[{"given":"Varun V.","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Drazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedy L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran K.","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"6","key":"15155_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","volume":"1","author":"KH Antman","year":"1983","unstructured":"Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1(6):386\u201391. https:\/\/doi.org\/10.1200\/JCO.1983.1.6.386.","journal-title":"J Clin Oncol"},{"issue":"7","key":"15155_CR2","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1245\/s10434-019-07414-8","volume":"26","author":"S Khan","year":"2019","unstructured":"Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. Incidence, risk factors, and prevention strategies for venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(7):2276\u201384. https:\/\/doi.org\/10.1245\/s10434-019-07414-8.","journal-title":"Ann Surg Oncol"},{"key":"15155_CR3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15030-4","author":"VV Bansal","year":"2024","unstructured":"Bansal VV, Mitchell O, Bregio C, et al. Venous thromboembolism in peritoneal mesothelioma: uncovering the hidden risk. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-15030-4.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"15155_CR4","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1245\/s10434-021-09973-1","volume":"28","author":"A Dhiman","year":"2021","unstructured":"Dhiman A, Fenton E, Whitridge J, et al. Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for patients undergoing cytoreductive surgery with or without HIPEC. Ann Surg Oncol. 2021;28(12):6955\u201364. https:\/\/doi.org\/10.1245\/s10434-021-09973-1.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"15155_CR5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","volume":"46","author":"M H\u00fcbner","year":"2020","unstructured":"H\u00fcbner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without Hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) Society recommendations\u2014Part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46(12):2292\u2013310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041.","journal-title":"Eur J Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15155-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:09:05Z","timestamp":1715087345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15155-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["15155"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15155-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MWD\u2014Personal fees from Cardinal Health Consulting and Argenx Consulting. HLK\u2014Nonfinancial support from AstraZeneca; personal fees from Tempus, Bluestar Genomics, Sanofi, Opna, AstraZeneca, Deciphera, Seageb, and Novocure. KKT\u2014Speaking fees from Aspire Bariatrics; Consultant for Merck. Other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was approved by the institutional review board of the University of Chicago.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The patients included in this study consented to participate in an IRB-approved mesothelioma registry at the University of Chicago.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}